An
Ethnopharmacological Approach to Multidrug-Resistant Staphylococcus
aureus:
Evaluation of Italian Plants used in the Traditional Healing of Skin Disease
One-third of botanical
remedies from southern Italy are used to treat skin and soft tissue infections
(SSTIs). Methicillin-resistant Staphylococcus aureus (MRSA), a common
cause of SSTIs, is responsible for increased morbidity and mortality from
infections. Therapeutic options are limited by antibiotic resistance.
Many plants possess potent antimicrobial compounds that provide effective
remedies for these disorders. Validation of traditional medical practices
is important for the people who rely on medicinal plants. Moreover, identification
of novel antibiotics and anti-pathogenic agents for MRSA is important
to healthcare on a global scale.
I took an ethnopharmacological
approach to understand how Italian medicinal plants used for the treatment
of SSTIs affect MRSA growth and virulence. My hypothesis was that plants
used in folk remedies for SSTI would exhibit lower mammalian cytotoxicity
and greater inhibition of bacterial growth, biofilm formation and toxin
production in MRSA than plants used for remedies unrelated to the skin
or for plants with no ethnomedical application. The field portion of my
research was conducted in the Vulture-Alto Bradano area of southern Italy.
I collected 104 plant species and created 168 crude extracts. In the lab,
I screened samples for activity against MRSA in a battery of bioassays.
Growth inhibition was analyzed using broth micro-titer assays for determination
of the minimum inhibitory concentration. Interference with quorum-sensing
(QS) processes, which mediate pathogenicity, was quantified through RP-HPLC
of d-toxin production. Interference with biofilm formation and adherence
was assessed using staining methods. The mammalian cytotoxicity of natural
products was analyzed using MTT cell proliferation assay techniques.
Although bacteriostatic
activity was limited, extracts from six plants used in Italian folk medicine
(Arundo donax, Ballota nigra, Juglans regia, Leopoldia comosa, Marrubium
vulgare, and Rubus ulmifolius) significantly inhibited biofilm formation
and adherence. Moreover, plants used to treat SSTI demonstrated significantly
greater anti-biofilm activity when compared to plants with no ethnomedical
application. QSI activity was evident in 90% of the extracts tested and
extracts from four plants (Ballota nigra, Castanea sativa, Rosmarinus
officinalis, and Sambucus ebulus) exhibited a significant dose-dependent
response. Some of the plant remedies for SSTI identified in this study
can be validated due to anti-MRSA activity.
In 2003, I wrote
a review paper on multidrug-resistant Staphylococcus aureus as
it relates to ethnopharmacology. Click here to view a PDF
of the document The Drug Resistance Paragon.
ABSTRACT
The need for structurally novel antimicrobial compounds has arisen with
the alarming fast evolution of multi-drug resistant pathogens over the
past twenty years. In this review, I will focus on Staphylococcus
aureus, the most common nosocomial pathogen today, and frequent carrier
of resistant genes for the pencillin antibiotics, tetracyclines, methicillin
and now, vancomycin. Much work on the synthetic development of compounds
similar to these has failed as pathogenic strains have quickly acquired
resistance. Natural products, however, hold a reservoir of many structurally
unique compounds and the potential for their medicinal activity has not
yet been fully explored. The interdisciplinary ethnopharmacological approach
to drug discovery through understanding the relationship between natural
products and bacterial resistance in S. aureus will be discussed.